🇺🇸 FDA
Patent

US 8333959

Ex-vivo application of solid microparticulate therapeutic agents

granted A61KA61K2035/124A61K35/12

Quick answer

US patent 8333959 (Ex-vivo application of solid microparticulate therapeutic agents) held by Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center
Grant date
Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2035/124, A61K35/12, A61K47/6901, A61K49/0002